Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
87
OBT Quote, Financials, Valuation and Earnings
Last price:
$28.56
Seasonality move
:
4.44%
Day range:
$27.33 - $28.01
52-week range:
$20.97 - $33.06
Dividend yield:
1.79%
P/E ratio:
11.56x
P/S ratio:
2.86x
P/B ratio:
1.85x
Volume:
75.2K
Avg. volume:
107.2K
1-year change:
-5.49%
Market cap:
$372.9M
Revenue:
$107.6M
EPS (TTM):
$2.42
Earnings Data
Next earnings date for OBT
Jul 31
2025
Most recent earnings per share
$0.77
Beat by $0.10
(Apr 30/2025)
Consensus Estimate
$0.67
(Apr 30/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
OBT Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $28.8M | -- | -- | $0.71 | -- |
| 07/31/2025 | Q2 | $28M | -- | -- | $0.75 | -- |
| 04/30/2025 | Q1 | $27M | $28M | $0.77 | $0.67 | $0.10 |
| 02/05/2025 | Q4 | $27.1M | $27.4M | $0.63 | $0.70 | -$0.07 |
| 10/30/2024 | Q3 | $25.3M | $27.1M | $0.29 | $0.75 | -$0.47 |
| 07/31/2024 | Q2 | $25.5M | $27.9M | $0.73 | $0.70 | $0.04 |
| 05/01/2024 | Q1 | $25.2M | $27.2M | $0.82 | $0.67 | $0.15 |
| 01/31/2024 | Q4 | $24.6M | $25.9M | $0.72 | $0.67 | $0.05 |
| 10/25/2023 | Q3 | $24.9M | $25.7M | $0.81 | $0.66 | $0.14 |
| 07/26/2023 | Q2 | $24M | $25.9M | $0.81 | $0.55 | $0.26 |
| 05/01/2023 | Q1 | -- | $19.3M | $0.29 | -- | -- |
| 01/25/2023 | Q4 | -- | $25.9M | $0.81 | -- | -- |
| 10/25/2022 | Q3 | -- | $24.3M | $0.70 | -- | -- |
| 08/01/2022 | Q2 | -- | $20.5M | $0.19 | -- | -- |
| 04/27/2022 | Q1 | -- | $19.2M | $0.48 | -- | -- |
| 01/26/2022 | Q4 | -- | $19.2M | $0.49 | -- | -- |
| 10/25/2021 | Q3 | -- | $18.8M | $0.53 | -- | -- |
| 08/12/2021 | Q2 | -- | $17.5M | $0.58 | -- | -- |
| 03/31/2021 | Q1 | -- | $16.5M | $0.56 | -- | -- |
| 12/31/2020 | Q4 | -- | $16M | $0.38 | -- | -- |
| 09/30/2020 | Q3 | -- | $15.2M | $0.33 | -- | -- |
| 06/30/2020 | Q2 | -- | $14.7M | $0.32 | -- | -- |
| 03/31/2020 | Q1 | -- | $13.7M | $0.28 | -- | -- |
| 12/31/2019 | Q4 | -- | $13.5M | $0.36 | -- | -- |
| 09/30/2019 | Q3 | -- | $14M | $0.35 | -- | -- |
| 06/30/2019 | Q2 | -- | $12.9M | $0.32 | -- | -- |
| 03/31/2019 | Q1 | -- | $12.4M | $0.25 | -- | -- |
| 12/31/2018 | Q4 | -- | $12.1M | $0.24 | -- | -- |
| 09/30/2018 | Q3 | -- | $11.5M | $0.26 | -- | -- |
| 06/30/2018 | Q2 | -- | $10.8M | $0.20 | -- | -- |
| 03/31/2018 | Q1 | -- | $10.5M | -- | -- | -- |
Orange County Bancorp Earnings Questions
-
How Much did Orange County Bancorp Generate in Revenue Last Quarter?
Orange County Bancorp reported $28M worth of top line sales in its most recent quarter.
-
Did Orange County Bancorp Beat Earnings Last Quarter?
Orange County Bancorp announced earnings per share of $0.77 which represents a beat of analyst forecast a $0.67 per share.
-
Is Orange County Bancorp Profitable?
Orange County Bancorp reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Orange County Bancorp EPS Next Year?
Orange County Bancorp's earnings are forecast to grow from $2.47 per share to $2.39 per share next year representing an increase of 17.27%.
-
When is Orange County Bancorp's Earnings Date?
Orange County Bancorp's next earnings date is July 31, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
